Promoter hypermethylation of SFRP1 as a prognostic and potentially predictive blood-based biomarker in patients with stage III or IV pancreatic ductal adenocarcinoma

Benjamin Stubbe*, Poul H. Madsen, Anders Christian Larsen, Henrik B. Krarup, Inge S. Pedersen, Julia S. Johansen, Stine D. Henriksen, Ole Thorlacius-Ussing

*Corresponding author for this work

Research output: Contribution to journalJournal articleResearchpeer-review

62 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Promoter hypermethylation of SFRP1 as a prognostic and potentially predictive blood-based biomarker in patients with stage III or IV pancreatic ductal adenocarcinoma'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science

Keyphrases